Skip to menu Skip to content Skip to footer

2014

Conference Publication

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR Γ GENE EXPRESSION IN THE AIRWAYS OF NON CYSTIC FIBROSIS BRONCHIECTASIS SUBJECTS IS INVERSELY CORRELATED WITH TOTAL PSEUDOMONAS AERUGINOSA BACTERIAL LOAD BUT POSITIVELY CORRELATED WITH ABSOLUTE MACROPHAGE LEVELS

Burr, L., Rogers, G., Chen, A. and Serisier, D. (2014). PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR Γ GENE EXPRESSION IN THE AIRWAYS OF NON CYSTIC FIBROSIS BRONCHIECTASIS SUBJECTS IS INVERSELY CORRELATED WITH TOTAL PSEUDOMONAS AERUGINOSA BACTERIAL LOAD BUT POSITIVELY CORRELATED WITH ABSOLUTE MACROPHAGE LEVELS. HOBOKEN: WILEY-BLACKWELL.

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR Γ GENE EXPRESSION IN THE AIRWAYS OF NON CYSTIC FIBROSIS BRONCHIECTASIS SUBJECTS IS INVERSELY CORRELATED WITH TOTAL PSEUDOMONAS AERUGINOSA BACTERIAL LOAD BUT POSITIVELY CORRELATED WITH ABSOLUTE MACROPHAGE LEVELS

2014

Conference Publication

Clinical Benefits of Long-Term, Low-Dose Erythromycin in Bronchiectasis Are Not Due to Modulation of Sputum Mucin Content

Chen, A., Martin, M., Lourie, R., Burr, L., Hasnain, S., Bowler, S., Mcguckin, M. and Serisier, D. (2014). Clinical Benefits of Long-Term, Low-Dose Erythromycin in Bronchiectasis Are Not Due to Modulation of Sputum Mucin Content. Annual Scientific Meeting of the Thoracic Society of Australia and New Zealand and the Australian and New Zealand Society of Respiratory Science 2014, Adelaide, SA Australia, 4-9 April 2014. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/resp.12263_6

Clinical Benefits of Long-Term, Low-Dose Erythromycin in Bronchiectasis Are Not Due to Modulation of Sputum Mucin Content

2014

Conference Publication

Domination of the Lower Airway Microbiota by Veillonella Species Is Predictive of Frequent Exacerbation in Non-Cystic Fibrosis Bronchiectasis

Rogers, G., Chen, A., Burr, L. and Serisier, D. (2014). Domination of the Lower Airway Microbiota by Veillonella Species Is Predictive of Frequent Exacerbation in Non-Cystic Fibrosis Bronchiectasis. Annual Scientific Meeting of the Thoracic Society of Australia and New Zealand and the Australian and New Zealand Society of Respiratory Science 2014, Adelaide, SA Australia, 4-9 April 2014. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/resp.12262_10

Domination of the Lower Airway Microbiota by Veillonella Species Is Predictive of Frequent Exacerbation in Non-Cystic Fibrosis Bronchiectasis

2014

Conference Publication

Human Neutrophil Elastase Activity and Matrix Metalloproteinase Activity Are Markers of Disease Severity in Non-Cf Bronchiectasis

Chen, A., Lourie, R., Martin, M., Burr, L., Hasnain, S., Fantino, E., Bowler, S., Mcguckin, M. and Serisier, D. (2014). Human Neutrophil Elastase Activity and Matrix Metalloproteinase Activity Are Markers of Disease Severity in Non-Cf Bronchiectasis. Thoracic Society of Australia & New Zealand and the Australian & New Zealand Society of Respiratory Science 2014 Annual Scientific Meetings, Adelaide Australia, 4-9 April 2014. Richmond, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/resp.12263_6

Human Neutrophil Elastase Activity and Matrix Metalloproteinase Activity Are Markers of Disease Severity in Non-Cf Bronchiectasis

2014

Journal Article

Miscellaneous antibacterial drugs

Burr, Lucy, Cunningham, Jordan and Serisier, David (2014). Miscellaneous antibacterial drugs. Side Effects of Drugs Annual, 36, 363-380. doi: 10.1016/B978-0-444-63407-8.00026-5

Miscellaneous antibacterial drugs

2014

Conference Publication

Proportional Antimicrobial Susceptibility Testing of Whole Cystic Fibrosis Sputum-A Pilot Study

Visser, S., Burr, L., Rogers, G. and Serisier, D. (2014). Proportional Antimicrobial Susceptibility Testing of Whole Cystic Fibrosis Sputum-A Pilot Study. Annual Scientific Meeting of the Thoracic Society of Australia and New Zealand and the Australian and New Zealand Society of Respiratory Science 2014, Adelaide, SA Australia, 4-9 April 2014. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/resp.12263_10

Proportional Antimicrobial Susceptibility Testing of Whole Cystic Fibrosis Sputum-A Pilot Study

2013

Conference Publication

Clinical Benefits Of Long-Term, Low-Dose Erythromycin In Bronchiectasis Are Not Due To Anti-Inflammatory Effects

Chen, A. C., Martin, M. M., Burr, L., Hasnain, S. Z., Lourie, R., Bowler, S. D., McGuckin, M. A. and Serisier, D. J. (2013). Clinical Benefits Of Long-Term, Low-Dose Erythromycin In Bronchiectasis Are Not Due To Anti-Inflammatory Effects. American Thoracic Society 2013 International Conference, Philadelphia, PA, United States, 17-22 May 2013. New York, United States: American Thoracic Society.

Clinical Benefits Of Long-Term, Low-Dose Erythromycin In Bronchiectasis Are Not Due To Anti-Inflammatory Effects

2012

Journal Article

An unusual radiological presentation of pulmonary Langerhans' cell histiocytosis

Burr, Lucy, Fanning, Steven, Wong, David and Bowler, Simon (2012). An unusual radiological presentation of pulmonary Langerhans' cell histiocytosis. BMJ Case Reports, 2012 (jul02 1), 1-4. doi: 10.1136/bcr-03-2012-5980

An unusual radiological presentation of pulmonary Langerhans' cell histiocytosis